Sleeping Pills and Their Side Effects in the UK

Quick Answer

Sleeping pills are not one single treatment. In the UK, the term may refer to prescription Z-drugs such as zopiclone and zolpidem, benzodiazepines such as temazepam, the orexin antagonist daridorexant, prescription melatonin, or sedating antihistamines sold for short-term sleep difficulty. Their benefits and risks differ. Common problems include next-day sleepiness, dizziness, poor balance, reduced concentration, dry mouth and headache. Some medicines can also cause unusual sleep behaviours, breathing problems, tolerance, dependence or withdrawal.

For long-term insomnia, UK guidance generally puts sleep assessment and cognitive behavioural therapy for insomnia (CBT-I) ahead of routine long-term sedative use. NICE recommends daridorexant only for specific adults with long-term insomnia when CBT-I has been tried but did not work, or when CBT-I is unavailable or unsuitable. No sleeping pill is automatically safe for every person with heart disease; the right choice depends on the heart condition, breathing, age, kidney or liver health and every other medicine being taken.

Key UK fact	What it means
2 to 4 weeks	Benzodiazepines and Z-drugs have traditionally been limited to short courses because benefits may reduce and dependence/withdrawal can develop.
3 nights a week for at least 3 months	Part of NICE eligibility criteria for daridorexant in adults with long-term insomnia, alongside CBT-I conditions.
67 million items	NHSBSA recorded about 67 million dependency-forming medicine items in England in 2024/25 across opioids, gabapentinoids, benzodiazepines and Z-drugs; this is not a sleeping-pill-only figure.
January 2026	MHRA strengthened UK warnings for benzodiazepines and Z-drugs about addiction, dependence, withdrawal and tolerance.

What Are the Types of Sleeping Pills?

A medicine should be described by its drug group, not simply as a “sleeping pill”, because the mechanism, licensed use and risk profile may differ. A product that helps one person fall asleep may be unsuitable for another person with sleep apnoea, frailty, pregnancy, a history of dependence, respiratory disease or interacting medication.

Type	UK examples or status	Main role	Important limitations
Z-drugs	Zopiclone and zolpidem; prescription only	Short-term treatment of severe insomnia	Next-day impairment, complex sleep behaviour, tolerance, dependence and withdrawal.
Benzodiazepines	Temazepam and nitrazepam; prescription controlled drugs	Selected cases of short-term severe insomnia	Sedation, falls, memory problems, dependence; additive breathing risk with opioids or alcohol.
Orexin receptor antagonist	Daridorexant; prescription only	NICE-approved option for qualifying long-term insomnia	Not first-line for everyone; sleepiness, headache and dizziness can occur; interactions require review.
Melatonin	Prescription only in the UK	Certain licensed age groups/conditions and specialist uses	Not an ordinary UK OTC supplement; interactions and side effects remain possible.
Sedating antihistamines	Diphenhydramine or promethazine products may be sold by pharmacies	Temporary sleep difficulty	Tolerance can develop quickly; dry mouth, blurred vision, constipation, confusion, urinary retention and next-day drowsiness.
Herbal products	Valerian or mixed herbal remedies sold as traditional products	Self-care chosen by some adults	Evidence and product quality vary; “natural” does not mean interaction-free or proven effective.

Prescription Sleeping Medicines

Zopiclone, zolpidem and benzodiazepines enhance inhibitory signalling in the nervous system and can reduce the time it takes to fall asleep. They do not repair every cause of insomnia. If pain, depression, anxiety, restless legs, sleep apnoea, thyroid disease, menopause symptoms, alcohol, shift work or another medicine is driving poor sleep, treating that cause may matter more than changing sedatives.

Daridorexant works differently by blocking orexin signalling involved in wakefulness. NICE does not recommend it as an unrestricted replacement for older medicines. The adult must meet long-term insomnia criteria, daytime functioning must be affected, and CBT-I must have been tried and failed, or be unavailable or unsuitable. Treatment should be reviewed within three months and stopped if there is no response.

Over-the-Counter Sleeping Pills

In the UK, pharmacy sleep aids commonly contain sedating antihistamines. “Over the counter” does not mean suitable for nightly or indefinite use. Diphenhydramine is used for short-term insomnia, but NHS advice notes that dependence can develop if it is taken too long without a break and that it may become less effective as the body gets used to it. Older adults are particularly vulnerable to confusion, blurred vision, constipation, urinary problems, dizziness and falls from anticholinergic medicines.

A pharmacist should check age, pregnancy or breastfeeding, glaucoma, prostate or urinary problems, epilepsy, breathing disease, other sedatives and current medicines. Do not combine two products just because both are non-prescription: cold-and-flu remedies, allergy medicines and night-time pain products may duplicate a sedating antihistamine.

Natural Sleeping Pills

The phrase “natural sleeping pills” is a marketing description rather than a guarantee of safety. Melatonin is a hormone the body makes, but medicinal melatonin is prescription-only in the UK. It can interact with other medicines and can still cause headache, dizziness, nausea or daytime sleepiness. Valerian and other herbal products may be sold under traditional herbal registration, which is not the same as strong proof that they treat chronic insomnia.

Herbal products may vary in ingredients and strength and can interact with alcohol, sedatives, anticoagulants or medicines processed by the liver. Tell the pharmacist or doctor about supplements exactly as you would mention a prescription. Avoid products from unregulated sellers because the stated ingredient or dose may not match the contents.

Treatment Details: How Sleeping Medicines Fit into UK Insomnia Care

Treatment begins with finding out what kind of sleep problem is present, how long it has lasted and how daytime life is affected. A GP may review sleep timing, snoring or pauses in breathing, restless legs, mood, pain, alcohol and caffeine, shift patterns and current medicines. A sleep diary is often more useful than guessing from one bad night.

Stage	Typical UK approach	Why it matters
Assessment	Confirm insomnia pattern; review physical, mental-health, breathing and medicine causes.	A sedative can mask a treatable cause or worsen an unrecognised breathing disorder.
Self-care	Regular wake time, appropriate time in bed, daylight/activity, less late caffeine and alcohol.	Supports the sleep-wake system, though sleep hygiene alone may not cure chronic insomnia.
CBT-I	Stimulus control, sleep scheduling, cognitive work and relapse prevention.	NICE regards CBT-I as standard first treatment for long-term insomnia after sleep-hygiene advice.
Short-course medicine	Used selectively when symptoms are severe or disabling.	The prescriber should agree purpose, duration, review and stopping plan before treatment starts.
Long-term option	Daridorexant only for adults meeting NICE criteria; review response.	Keeps prescribing tied to eligibility, benefit and ongoing daytime impact.

For the full non-drug and GP pathway, read Insomnia Treatment in the UK.

Risks and Benefits

A benefit is meaningful only when it improves the person’s target problem enough to outweigh harm. A short course may help someone through severe temporary insomnia, but the same medicine can be a poor choice if it causes unsafe driving, falls, confusion or breathing difficulty. The lowest effective dose for the shortest appropriate duration is a common safety principle, not a personal dosing instruction.

Possible benefit	Possible cost or uncertainty	Review question
Falling asleep sooner	Next-day drowsiness or slowed reaction time	Can the person function and drive safely the next day?
Fewer night awakenings	Dizziness, falls, memory or attention problems	Has the improvement produced better daytime function?
Short-term relief during a crisis	Tolerance, dependence or rebound insomnia if use continues	Was an end date and stopping plan agreed?
Reduced wakefulness with daridorexant	Sleepiness, dizziness, headache and medicine interactions	Does the patient meet NICE criteria and respond by review?
Perceived benefit from OTC/herbal products	Weak evidence, tolerance, interactions or duplicated ingredients	Has a pharmacist checked the exact product and medicine list?

Common Side Effects of Sleeping Pills

Side effects depend on the medicine and the person. Common class-wide complaints include daytime sleepiness, dizziness, unsteadiness, slower thinking, reduced concentration, headache, nausea and dry mouth. Zopiclone often causes a bitter or metallic taste. Sedating antihistamines can cause anticholinergic effects such as blurred vision, constipation and difficulty passing urine. Longer-acting medicines are more likely to cause a “hangover” effect.

Do not drive, cycle or use machinery if sleepy, dizzy, confused or less alert.
Avoid alcohol; it can deepen sedation and increase breathing, memory and accident risks.
Seek urgent help for difficulty breathing, severe confusion, inability to wake, facial or throat swelling, or dangerous unusual behaviour.

For one medicine in detail, see the dedicated zopiclone side-effects guide.

What Are the Potential Long-Term Side Effects of Sleeping Pills?

Long-term risk cannot be reduced to one list because antihistamines, benzodiazepines, Z-drugs, melatonin and orexin antagonists are different. The best-established concerns for regular benzodiazepine and Z-drug use are tolerance, physical dependence, withdrawal, rebound insomnia and impairment. Falls, fractures and confusion are particular concerns in older or frail adults. Evidence linking particular sleep medicines to dementia or death is often observational and can be affected by age, illness, insomnia severity and other medicines; it should not be presented as proof of direct causation.

The MHRA’s January 2026 review concluded that warnings about addiction, dependence, withdrawal and tolerance for benzodiazepines and Z-drugs needed strengthening. Patients should be told about duration and stopping plans, should not share medicines, and should avoid combining them with alcohol or opioids. Do not stop regular use abruptly without individual advice.

Long-term concern	What it can look like	Safer response
Tolerance	The same dose seems less effective.	Do not increase the dose yourself; request a treatment review.
Physical dependence	Withdrawal symptoms appear when a dose is reduced or missed.	Use an individual, clinician-led gradual reduction when appropriate.
Rebound insomnia	Sleep temporarily becomes worse after stopping.	Plan support and distinguish rebound from the original condition.
Cognitive or balance impairment	Forgetfulness, slowed reactions, falls or daytime confusion.	Review medicine, dose, timing, other sedatives and fall risk.
Persistent underlying insomnia	Medicine is continued while the cause remains untreated.	Reassess for CBT-I, sleep apnoea, mood, pain, restless legs or other drivers.

Recovery and Outlook

Many short-term side effects improve as the medicine wears off or after treatment is changed, but recovery varies. A person who has taken a benzodiazepine or Z-drug regularly may need a gradual, individual reduction. NICE withdrawal guidance says the plan should be flexible and adjusted to symptoms; a fixed online taper schedule is not safe for everyone. Withdrawal can include anxiety, agitation, sweating, tremor, sleep disturbance, sensory symptoms and, in severe cases, seizures.

The outlook is better when the original sleep problem is treated alongside medicine reduction. CBT-I can provide skills that remain useful after tablets stop. If dependence or loss of control has developed, this is a health problem rather than a moral failure. A GP, pharmacist or local drug and alcohol service can help. Call 999 for a seizure, severe breathing difficulty, collapse, suspected overdose or immediate danger.

What Are Safe Sleeping Pills for Heart Patients?

There is no universally “safest sleeping pill” for heart patients. Heart disease includes very different problems—high blood pressure, rhythm disorders, angina, heart failure, valve disease and recovery after a heart attack. The patient may also take anticoagulants, antiplatelets, beta-blockers, anti-arrhythmics, diuretics or opioids. A medicine that is reasonable in one situation may be unsafe in another.

The safest first step is usually to investigate why sleep is poor. Breathlessness when lying flat, night-time chest pain, palpitations, diuretic timing, depression, restless legs and obstructive sleep apnoea can all disturb sleep and may need direct treatment. Sedatives may worsen breathing or hide symptoms. Untreated sleep apnoea is especially important because it is linked with cardiovascular disease and can be aggravated by some sedating medicines.

Heart-related factor	Why it changes the decision	What to ask the clinician
Heart rhythm/QT risk	Some sedating or off-label medicines can affect cardiac conduction.	Does this medicine or combination require avoidance or ECG review?
Heart failure or night breathlessness	Poor sleep may reflect fluid overload or sleep-disordered breathing.	Should the heart condition or sleep apnoea be assessed before a sedative?
Blood-pressure treatment	Added dizziness may increase fainting or fall risk.	Could bedtime medicines together lower alertness or blood pressure too much?
Anticoagulants/antiplatelets	Falls become more consequential; herbal interactions may matter.	Has the pharmacist checked the exact supplement and medicine list?
Opioid pain medicines	Combining opioids with benzodiazepines or Z-drugs can cause additive respiratory depression, coma and death.	Is there a non-sedating alternative, and what monitoring is required?
Suspected sleep apnoea	Sedation can worsen airway or breathing problems in susceptible people.	Is sleep assessment needed before starting or continuing medication?

Do not replace a prescribed medicine with melatonin or a “natural” product without review. NHS guidance notes that melatonin can interact with medicines, and the safety of many herbal combinations is uncertain. Bring the actual boxes or a complete medicine list to the pharmacist or GP.

How to Use Sleeping Medicines More Safely

Use only the medicine prescribed or supplied for you, exactly as directed; never share it.
Agree the target symptom, expected duration, review point and stopping plan.
Check OTC and herbal products with a pharmacist, especially with heart, breathing, liver or kidney conditions.
Avoid alcohol, opioids and additional sedatives unless the prescriber has specifically reviewed the combination.
Allow the full sleep time advised for the medicine and avoid driving if next-day alertness is reduced.
Seek review if the medicine stops working, is needed more often, causes unusual sleep behaviour or feels difficult to reduce.

For alcohol-specific risks, read Zopiclone and Alcohol: Risks and Safety Advice.

Frequently Asked Questions

Are sleeping pills safe for long-term use?

Some medicines have limited longer-term roles, but benzodiazepines and Z-drugs are generally used short term because tolerance, dependence and withdrawal can occur. Long-term treatment needs regular review.

Can I buy melatonin over the counter in the UK?

No. Medicinal melatonin is prescription-only in the UK. Products bought abroad or online may not meet UK quality and prescribing safeguards.

Are antihistamine sleep aids safer than prescription tablets?

Not automatically. They can cause next-day drowsiness, confusion, dry mouth, blurred vision, constipation, urinary retention and falls, and tolerance may develop.

Are natural sleeping pills risk-free?

No. Herbal products may have uncertain evidence, variable ingredients and medicine interactions. Natural origin does not guarantee safety.

Why do sleeping pills stop working?

Tolerance, a changing sleep problem, an untreated cause or incorrect timing may contribute. Do not increase the dose yourself; ask for review.

Can sleeping pills affect memory and attention?

Yes. Several sedatives can slow thinking, reduce concentration or cause memory problems, particularly with higher exposure, alcohol, other sedatives or older age.

Can sleeping pills worsen breathing?

Some sedatives can depress breathing or worsen sleep-disordered breathing. Risk rises with opioids, alcohol and certain respiratory conditions.

Should I stop if I have side effects?

Seek advice. Urgent symptoms need urgent help, but regular benzodiazepine or Z-drug use should not usually be stopped abruptly without a personalised plan.

What is the safest sleeping pill for a heart patient?

There is no universal answer. A doctor or pharmacist must review the heart diagnosis, breathing, fall risk, liver/kidney function and all other medicines.

What is the best long-term treatment for chronic insomnia?

CBT-I is the standard first treatment in UK guidance after sleep-hygiene advice. Medicine may be considered for selected people after assessment.

Sources

Conclusion

Sleeping pills can offer short-term relief, but the correct choice depends on the type of insomnia, the specific medicine and the person’s health. UK readers should not treat pharmacy products, melatonin or herbal remedies as automatically harmless. The safest plan connects assessment, CBT-I or treatment of the underlying cause with a clear medicine purpose, review and stopping plan. People with heart disease should never choose a sleep medicine from a generic “safe list”; their diagnosis, breathing and complete medicine list must be reviewed.

Sleeping medicines can cause serious side effects and interactions.
Use prescription medicines only as prescribed for you.
Do not mix sleeping medicines with alcohol, opioids or other sedatives unless a clinician has reviewed the combination.
Do not stop regular benzodiazepine or Z-drug use suddenly without medical advice.

Sleeping Pills and Their Side Effects in the UK